Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

44806 ARTÍCULOS , VIENDO DEL 511 AL 525

Neuroinflammation and metabolic reprogramming in Parkinson's disease

Fu Y, Yu J, Xu L, Zhou T, Deng Q.

Front Immunol. 2026 Sep 11;17:1857394. doi: 10.3389/fimmu.2026.1857394. eCollection 2026.

Efficacy of Curcumin in Neurodegenerative Diseases: From Pharmacokinetic Barriers to Advanced Delivery Systems

Castello-Guillen A, Garrido-Reig M, Caplliure-Llopis J, Vega-Bello MJ, Almela C, de la Rubia Ortí JE.

Pharmaceuticals (Basel). 2026 Sep 6;19(9):1405. doi: 10.3390/ph19091405.

Digital biomarkers derived from wearable sensors in neurorehabilitation: a scoping review

Shalabi KM, Mahmoud H, Pakkir Mohamed SH, Shaik SA.

Front Neurol. 2026 Sep 3;17:1908796. doi: 10.3389/fneur.2026.1908796. eCollection 2026.

From HIV to SARS-CoV-2 associated neurological disorder ("HAND" to "SAND"): Viral infection as a "time-bomb" for the aging brain

Millan MJ.

Neurosci Appl. 2026 Aug 29;5:107024. doi: 10.1016/j.nsa.2026.107024. eCollection 2026.

Interpreting Viral Associations in Neurodegenerative Diseases

Hedström AK.

Int J Mol Sci. 2026 Sep 15;27(18):8185. doi: 10.3390/ijms27188185.

HIV-1 Tat and gp120 as key drivers of neurodegeneration in the central nervous system

Cecchetto R, Diani E, Lotti V, Palmisano A, Lagni A, Mantoan M, Turrina S, Raniero D, Paolone G, Mazzariol A, Gibellini D.

Front Microbiol. 2026 Aug 12;17:1895162. doi: 10.3389/fmicb.2026.1895162. eCollection 2026.

Attitudes, Strategies and Value Frameworks Guiding Risk Communication in Isolated REM Behaviour Disorder: A Scoping Review of Perspectives From Patients and Healthcare Professionals

Covino S, Borovecki A, Ćurković M, Vecchia LAD, De Maria B, Gino C, Grossi A, Picozzi M, Sattin D; DEEPEN iRBD Consortium.

J Sleep Res. 2026 Sep 23:e70455. doi: 10.1111/jsr.70455. Online ahead of print.

Pharmacological modulation of cGAS-STING-NLRP3 signaling by nano-immunomodulators in Alzheimer and Parkinson disease

Abdel-Rasol MA.

Inflammopharmacology. 2026 Oct;34(10):6451-6485. doi: 10.1007/s10787-026-02386-0. Epub 2026 Sep 15.

[A New Understanding of the Amyotrophic Lateral Sclerosis/Parkinsonism-Dementia Complex in the Kii Peninsula, Japan, 2026]

Kokubo Y.

Brain Nerve. 2026 Sep;78(9):1023-1029. doi: 10.11477/mf.188160960780091023.

ACE2 dysregulation and lipid metabolism: Mechanistic interplay between COVID-19 and neurodegeneration

Orzeł U, Wójcik E, Filipek S, Moreira IS.

Mol Aspects Med. 2026 Sep 17;112:101519. doi: 10.1016/j.mam.2026.101519. Online ahead of print.

Adult-recognized 22q11.2 deletion syndrome in adult neurology practice: a brief report of two diagnostic pitfalls

Wu D, Wang Y, Sun D, Wang J, Wang X.

Front Neurol. 2026 Aug 31;17:1933196. doi: 10.3389/fneur.2026.1933196. eCollection 2026.

Enhancing the glymphatic system as a potential pathway to limit Parkinson disease progression

Yan Z, Howitt J.

Expert Opin Ther Targets. 2026 Sep 24:1-4. doi: 10.1080/14728222.2026.2738182. Online ahead of print.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias